Newcastle University, UK, which launched the MSc Oncology for the pharma industry, as a part of the MSc Oncology and Palliative Care e-learning programmes in 2012, will have two new modules in the new academic year: Health Economics, and Cancer Drugs and Technologies. 120 students were registered across the three e-learning programmes (MSc in Oncology, MSc in Palliative Care and MSc in Oncology for the Pharmaceutical Industry) in 2012. Students from Australia, Canada, Greece, Malta, South Africa, India, Singapore, Saudi Arabia, the US, Ghana, Kenya, Egypt and New Zealand, enrolled for the courses.
The programme has been designed to enable students to gain an insider’s look into the hospitals’ expectations from the pharma industry and the impact of regulatory procedures. It also focuses on the implications of legislation and economic environment, and how pharmacists need to adapt to the changing sector by developing business skills. Ethical perspectives complement the scientific and business dimensions of the programme. Two new modules will be added to the programme for the new academic year: Health Economics, and Cancer Drugs and Technologies.
Dr Charles Kelly, Degree Programme Director said, “Students will gain knowledge that helps them build awareness of National Health Service (NHS) procedures. One of the main goals of the course is to help increase the understanding and cooperation between the pharma industry and NHS by helping students understand how decisions are made in adopting certain techniques, with the patient at the centre of the decision making process.”
EP News Bureau – Mumbai